✦ LIBER ✦
1090 Continuation of irinotecan (CPT-11) beyond 8 cycles does not improve outcome in patients with advanced colorectal cancer resistant to fluoropyrimidines: results of a phase III multi-centre randomised trial
✍ Scribed by Dickson, J.L.B.; Lal, K.R.; Norman, A.R.; Ross, P.J.; Oates, J.; Massey, A.; Hill, M.E.; Middleton, G.; Topham, C.; Cunningham, D.
- Book ID
- 123269898
- Publisher
- Elsevier Science
- Year
- 2003
- Tongue
- English
- Weight
- 164 KB
- Volume
- 1
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.